A novel anti-HBeAg homolignan, taiwanschirin D from Kadsura matsudai

Chem Pharm Bull (Tokyo). 2000 Dec;48(12):1992-3. doi: 10.1248/cpb.48.1992.

Abstract

A novel C19 homolignan, taiwanschirin D (1), possessing a 3,4-(1-[(Z)-2-methoxy-2-oxoethylidenel)pentano (2,3-dihydrobenzo[b]furan)-3(2-oxoacetate) skeleton, was isolated from the stem of Kadsura matsudai Hayata. Its structure was determined from physical and spectral data including 2D NMR spectra. The Anti-HBeAg test revealed that taiwanschirin D (1) had moderate activity at a concentration of 94.3 microM (50 microg/ml).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / isolation & purification
  • Antineoplastic Agents / pharmacology
  • Antiviral Agents / chemistry
  • Antiviral Agents / isolation & purification*
  • Antiviral Agents / pharmacology
  • Cell Survival / drug effects
  • HeLa Cells
  • Hepatitis B virus / drug effects
  • Humans
  • KB Cells
  • Lignans / chemistry
  • Lignans / isolation & purification*
  • Lignans / pharmacology
  • Magnoliopsida / chemistry*

Substances

  • Antineoplastic Agents
  • Antiviral Agents
  • Lignans
  • taiwanschirin D